Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet
Reviewed educational reference: what Glimepiride + Metformin Hydrochloride is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Glimepiride + Metformin Hydrochloride
- Strength
- 2mg + 500mg
- Dosage form
- Sustained Release Tablet
- Drug class
- Sulfonylurea + Biguanide
Related products
No reviewed products are currently published for this generic.
Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet is a combination oral antidiabetic medication containing Glimepiride + Metformin Hydrochloride. It is indicated for the management of type 2 diabetes mellitus in patients who cannot achieve adequate glycemic control with diet, exercise, and monotherapy. By combining two distinct mechanisms of action, Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet provides comprehensive control over both fasting and postprandial blood glucose levels.
At a glance
Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet is a combination of glimepiride and metformin hydrochloride.
It lowers blood glucose levels by stimulating insulin release and improving insulin sensitivity.
It is used for the management of type 2 diabetes mellitus in adults.
Uses of Glimepiride + Metformin Hydrochloride
- Management of type 2 diabetes mellitus
- Improvement of glycemic control in adults
- Reduction of fasting plasma glucose
- Reduction of postprandial blood glucose
- Adjunct to diet and exercise
- Prevention of diabetic complications through glucose control
Benefits of Glimepiride + Metformin Hydrochloride
Dual Mechanism of Action
The combination of Glimepiride + Metformin Hydrochloride targets diabetes from two directions. Glimepiride stimulates the pancreas to release more insulin, while Metformin improves the body's sensitivity to insulin and reduces glucose production in the liver. This synergistic approach is often more effective than using either drug alone.
Convenience and Compliance
Using a fixed-dose combination like Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet reduces the total number of pills a patient needs to take daily. This simplification of the medication regimen often leads to better adherence, which is critical for maintaining stable blood sugar levels and preventing long-term complications of diabetes.
Side effects of Glimepiride + Metformin Hydrochloride
The most common side effect of Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet is hypoglycemia, which is more likely to occur if meals are skipped or delayed. Symptoms include shakiness, sweating, dizziness, and confusion. Gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain are frequently reported, particularly during the initial phase of treatment with Metformin. These symptoms are often transient and can be minimized by taking the medication with food. Less common but serious side effects include lactic acidosis, a rare but life-threatening metabolic complication associated with Metformin, and allergic skin reactions. If you experience persistent stomach pain, unusual muscle weakness, or difficulty breathing, seek medical attention immediately.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Hypoglycemia | Common | Moderate | Consume fast-acting carbohydrates. |
| Gastrointestinal upset | Very common | Mild | Take with food. |
| Lactic acidosis | Very rare | Life-threatening | Seek emergency care. |
How to manage side effects
Hypoglycemia
- 1. Recognize symptoms like shaking and sweating.
- 2. Check blood glucose.
- 3. Consume 15g of glucose.
- 4. Recheck in 15 minutes.
Gastrointestinal upset
- 1. Take the tablet during a meal.
- 2. Increase dose gradually if advised.
- 3. Consult doctor if symptoms persist.
Lactic acidosis
- 1. Stop the medication immediately.
- 2. Go to the nearest emergency room.
- 3. Inform staff about metformin use.
How to use Glimepiride + Metformin Hydrochloride
- Take Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet exactly as prescribed by your physician.
- Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.
- Take this medication with a meal to reduce the risk of stomach upset.
- Follow a consistent meal schedule to prevent low blood sugar episodes.
- Monitor your blood glucose levels regularly as advised by your healthcare provider.
Special population advice
Kidney impairment
- Contraindicated in severe impairment (eGFR <30 mL/min).
- Monitor renal function regularly.
Liver impairment
- Use with caution.
- Monitor liver function tests periodically.
Children
- Not recommended for use in patients under 18.
Elderly
- Start with lower doses.
- Monitor for hypoglycemia closely.
How Glimepiride + Metformin Hydrochloride works
Glimepiride acts as a sulfonylurea by binding to receptors on pancreatic beta cells, stimulating insulin secretion. Metformin, a biguanide, works primarily by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time to make up for a forgotten one.
In case of overdose
An overdose of Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet can lead to severe hypoglycemia, characterized by extreme weakness, sweating, tremors, and loss of consciousness. It may also cause lactic acidosis due to the Metformin component. If you suspect an overdose, seek emergency medical help immediately or contact a poison control center.
Treatment is supportive and symptomatic.
- Hypoglycemia
- Administer glucose orally or intravenously.
- Lactic Acidosis
- Discontinue drug and provide supportive care, potentially hemodialysis.
- Gastric Decontamination
- Consider activated charcoal if ingestion was recent.
- Monitoring
- Monitor blood glucose and electrolytes for at least 24-48 hours.
Safety and precautions
When to avoid Glimepiride + Metformin Hydrochloride
- Severe renal impairment
Risk of metformin-associated lactic acidosis.
- Diabetic ketoacidosis
Requires insulin therapy, not oral agents.
- Hepatic impairment
Requires careful monitoring of liver function.
- Elderly patients
Increased risk of hypoglycemia.
- Surgery
Metformin should be temporarily discontinued.
- Contrast studies
Discontinue metformin before procedures involving iodinated contrast.
Safety at a glance
Avoid excessive alcohol as it increases the risk of hypoglycemia and lactic acidosis.
Consult your doctor; insulin is generally preferred over oral agents during pregnancy.
Consult your doctor before use as the drug may pass into breast milk.
Be aware of hypoglycemia symptoms which can impair your ability to drive.
Do not use if you have severe renal impairment; monitor kidney function regularly.
Use with caution in patients with hepatic impairment; monitor liver enzymes.
Do not use if you have a known allergy to sulfonylureas or metformin.
Not recommended for use in children under 18 years of age.
Use with caution due to higher risk of hypoglycemia and age-related renal decline.
Interactions
With other medicines
Beta-blockers
ModerateChanges the medicine’s effect
What can happen: Masks hypoglycemia symptoms.
What to do: Monitor blood glucose more frequently.
Corticosteroids
ModerateChanges the medicine’s effect
What can happen: Increases blood glucose levels.
What to do: Adjust dose of Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet as needed.
NSAIDs
MinorChanges the medicine’s effect
What can happen: May enhance hypoglycemic effect.
What to do: Monitor for signs of low blood sugar.
With food and drink
- AlcoholMajor
Increases risk of hypoglycemia and lactic acidosis.
- High-fiber mealsMinor
May slightly reduce the absorption of metformin.
If you have another condition
- Renal failure
Metformin is contraindicated in severe renal failure.
- Liver disease
May impair metabolism of glimepiride.
Effect on laboratory tests
- HbA1c
<b>Decreased levels</b>
Reflects improved glycemic control.
- Serum Creatinine
<b>Increased levels</b>
May indicate renal impairment requiring dose adjustment.
Quick tips
- Carry a source of fast-acting sugar, such as glucose tablets or fruit juice, to treat sudden hypoglycemic episodes.
- Inform your doctor if you are planning any surgical procedures or diagnostic tests involving contrast dyes.
- Avoid excessive alcohol consumption, as it can significantly increase the risk of hypoglycemia and lactic acidosis.
- Wear a medical alert bracelet indicating that you have diabetes and are taking medication.
- Attend regular check-ups to monitor your kidney and liver function.
Counselling points
- HypoglycemiaImportant
Learn the signs of low blood sugar and carry sugar sources.
- DietImportant
Maintain a consistent meal pattern to avoid glucose fluctuations.
- AlcoholGood to know
Limit alcohol intake to prevent dangerous metabolic side effects.
- Medical AlertOptional
Wear an ID bracelet stating you have diabetes.
Monitoring during treatment
Before starting
- Fasting blood glucose
- HbA1c
- Serum creatinine
- Liver function tests
During treatment
- every 3 months: HbA1c and renal function tests
What is being watched
- Blood glucose
- Renal function
- Liver enzymes
Pharmacokinetics
- Absorption
- Glimepiride is completely absorbed; Metformin is slowly absorbed.
- Bioavailability
- High for both components.
- Protein binding
- Glimepiride >99%.
- Volume of distribution
- Glimepiride 8.8 L.
- Half-life
- Glimepiride 5-9 hours; Metformin 6.2 hours.
- Metabolism
- Glimepiride via CYP2C9; Metformin is not metabolized.
- Excretion
- Glimepiride via urine and feces; Metformin via urine.
- Onset / duration
- Rapid onset with sustained effect.
Fact box
- Chemical class
- Sulfonylurea + Biguanide
- Habit forming
- No
- Therapeutic class
- Antidiabetic
- Action class
- Hypoglycemic agent
- Storage
- Store at room temperature between 20°C and 25°C. Keep in a dry place, away from direct sunlight and moisture. Keep out of reach of children.
- ATC code
- A10BD02
- Pregnancy category
- C
More information
Clinical Rationale for Combination Therapy
Clinicians often transition patients to a fixed-dose combination like Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet when monotherapy with metformin or a sulfonylurea fails to reach target HbA1c levels. The rationale is based on the complementary nature of the two agents. Metformin addresses the insulin resistance and hepatic glucose output that are hallmarks of type 2 diabetes, while glimepiride addresses the progressive decline in beta-cell function. By using both, the clinician can often achieve better glycemic control with lower individual doses of each agent, potentially reducing the dose-dependent side effects of each. This approach is supported by guidelines that advocate for early combination therapy to prevent the 'clinical inertia' that occurs when patients remain on ineffective monotherapy for too long.
Comparing Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet with Other Antidiabetics
When compared to newer classes of antidiabetics like SGLT2 inhibitors or GLP-1 receptor agonists, Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet remains a cost-effective and highly reliable option for many patients in India. While newer agents offer benefits such as weight loss or cardiovascular protection, they are often significantly more expensive. Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet provides a robust reduction in HbA1c that is well-documented in clinical literature. The primary trade-off is the risk of hypoglycemia and weight gain associated with the sulfonylurea component, which is less prevalent with newer classes. Clinicians must weigh the patient's financial situation, cardiovascular risk profile, and lifestyle when choosing between this combination and newer, more expensive therapies.
Lifestyle and Dietary Considerations
Taking Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet is not a substitute for lifestyle modification. Patients must adhere to a structured diet that emphasizes low-glycemic index carbohydrates, high fiber, and lean proteins. Regular physical activity is essential, as it enhances the insulin-sensitizing effects of metformin. However, patients should be cautioned that intense, unplanned exercise can trigger hypoglycemia when taking a sulfonylurea. It is recommended to check blood glucose levels before and after exercise. Furthermore, patients should avoid 'yo-yo' dieting and ensure that meals are not skipped, as the glimepiride component continues to stimulate insulin release regardless of food intake, creating a high risk for hypoglycemia if the patient is fasting.
Managing Treatment Expectations
Patients starting Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet should be informed that the goal of therapy is long-term glycemic stability, not immediate normalization of blood sugar. It may take several weeks for the full therapeutic effect to be reflected in HbA1c levels. During the first few weeks, patients may experience mild gastrointestinal side effects from the metformin, which typically subside as the body adjusts. It is important to encourage patients to persist with the medication during this adjustment period rather than stopping it. Regular monitoring of blood glucose at home is the best way for patients to see the progress they are making and to identify any patterns that require a discussion with their healthcare provider.
References
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
- National Agency for Food and Drug Administration and Control. SmPC for Glimepiride/Metformin.View sourceAccessed
- Electronic Medicines Compendium. Glimepiride/Metformin tablets Summary of Product Characteristics.View sourceAccessed
- NAFDAC Nigeria. Glimson SmPC documentation.View sourceAccessed
- Medical Products Agency Sweden. Glimepirid Actavis SmPC.View sourceAccessed
Frequently asked questions about Glimepiride + Metformin Hydrochloride
Can I stop taking Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet if my blood sugar is normal?
No, you should continue taking the medication as prescribed. Normal blood sugar levels indicate the medication is working, not that the diabetes is cured.
What should I do if I feel dizzy after taking the tablet?
Dizziness may be a sign of low blood sugar. Check your glucose levels and consume a fast-acting carbohydrate if it is low.
Is it safe to take Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet with other diabetes medications?
Only if directed by your doctor. Combining multiple antidiabetic agents increases the risk of hypoglycemia.
How long does it take for Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet to show results?
While it starts working shortly after ingestion, it may take several weeks to see the full effect on your HbA1c levels.
Does Glimepiride + Metformin Hydrochloride 2mg + 500mg Sustained Release Tablet cause weight gain?
Glimepiride can sometimes lead to weight gain, while metformin is weight-neutral or may cause slight weight loss. The overall effect varies by individual.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →